Rossari Biotech Ltd. News and Updates

Name: Latest research reports of Rossari Biotech Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Rossari Biotech Ltd.
Rating: 3
Author: ICICI Securities Limited

Keep track of all breaking news on Rossari Biotech Ltd. from all sources in a single place.

Load latest

Rossari Biotech Ltd.

21 Oct 2024

688.80

1.56%

Exports drive revenue growth

Hold: Rossari Biotech Ltd.

Recommendation Target

ICICI Securities Limited

Rossari Biotech’s (Rossari) Q2FY25 HPPC revenue growth (+6.2% YoY) was hurt from softer demand and restricted ethylene oxide (EO) capacity.

Rossari Biotech Ltd. has lost -20.13% in the last 6 Months

Rossari Biotech Ltd.

19 Oct 2024

688.80

1.56%

Rossari Biotech Q2 Results: Profit Rises 7.3%; Arm To Acquire Thailand-Based Unistar Thai

NDTV Profit

Unistar Thai Co. is a newly incorporated company in the chemicals and consumer products industry and is yet to commence its operations.

Rossari Biotech Ltd. has lost -20.13% in the last 6 Months

Rossari Biotech Ltd.

24 Jul 2024

688.80

1.56%

Top-line to grow with the support of volume

Buy: Rossari Biotech Ltd.

Target

KRChoksey

Rossari Biotech’s revenue beat our estimate (+2.8%) due to strong volume growth in HPPC (Home, Personal Care, and Performance Chemicals) business and in the TSC (Textile Specialty Chemicals) division.
We anticipate this growth momentum in revenue will continue due to strong demand in the end customer segments.

Rossari Biotech Ltd. is trading above its 50 day SMA of 650.2

Rossari Biotech Ltd.

22 Jul 2024

688.80

1.56%

Rossari Biotech Results Earnings Call for Q1FY25

Conference Call with Rossari Biotech Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.

audio

Rossari Biotech Ltd.

22 Jul 2024

688.80

1.56%

to see Rapid results content

Rossari Biotech Ltd.

13 Jun 2024

688.80

1.56%

Diversified business mix; no major China competition; initiating, with a Buy

Buy: Rossari Biotech Ltd.

Anand Rathi

Rossari Biotech is a leading specialty chemicals manufacturing company, focusing on four core chemistries of enzymes, silicones, acrylics and surfactants. It caters to industries such as home and personal care, and performance chemicals (HPPC), textile specialty chemicals (TSC) and animal health and nutrition (AHN) products

Rossari Biotech Ltd. is trading at high day volume of 224.7K.

Rossari Biotech Ltd.

08 May 2024

688.80

1.56%

Strong growth in HPPC segment drives the performance

Buy: Rossari Biotech Ltd.

Target

KRChoksey

Rossari Biotech missed our revenue estimate due to subdued growth In Textile Specialty Chemical segment and Animal Health Nutrition segment which was partially offset by growth in Home, Personal care and Performance chemicals (HPPC) segment.
The stock is trading at PE multiples of 23.3x/18.9x based on FY25E/FY26E EPS estimates, respectively.

Rossari Biotech Ltd. has an average target of 939.75 from 4 brokers.

Rossari Biotech Ltd.

02 May 2024

688.80

1.56%

Rossari Biotech Q4 Results Review - HPPC Pie Is Now More Broad-Based: Nirmal Bang

NDTV Profit

Expansion projects with peak revenue potential of Rs 4 billion

Rossari Biotech Ltd. has an average target of 939.75 from 4 brokers.

Rossari Biotech Ltd.

01 May 2024

688.80

1.56%

Rossari Biotech | Q4FY24 Result Update

Buy: Rossari Biotech Ltd.

Target

Edelweiss

HPPC and capex to drive growth

Rossari Biotech Ltd. has an average target of 939.75 from 4 brokers.

Rossari Biotech Ltd.

30 Apr 2024

688.80

1.56%

Rossari Biotech Results Earnings Call for Q4FY24

Conference Call with Rossari Biotech Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
Management in attendance

audio